Hillan Kenneth J.
SEC insider (Form 3/4/5 filer). CIK 0001600359. Director at SANGAMO THERAPEUTICS, INC (SGMO). 1 reported Form 4/5 transaction since Sep 2024; latest on Jun 12, 2025. Located in RICHMOND, CA.
Companies Hillan Kenneth J. has filed insider reports for
- SANGAMO THERAPEUTICS, INC (SGMO): Director
Hillan Kenneth J.
CIK: 0001600359
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SGMO
SANGAMO THERAPEUTICS, INC
Director